{"entity":{"id":"16861bf3-5842-5d52-af27-ab2a3e8d49d7","name":"SHIRE PHARMACEUTICAL INVESTMENT HOLDINGS LIMITED","type":"Company","kind":"company","jurisdiction":"MT","identifier":"icij:icijol-55033389","risk":"HIGH","flags":[]},"identity":{"linked_records":[],"also_known_in":[]},"ownership":{"direct_owners":[{"role":"secretary of","share":null,"party":{"id":"ed0b7986-578b-5d86-92d0-d3a3b601e2d7","name":"MICHAEL C. SCHMIDT","type":"Organization","kind":"company"}},{"role":"director of","share":null,"party":{"id":"76c2477d-e412-5853-a58f-174fb6eb0b08","name":"MICHAEL E. CHAPMAN","type":"Organization","kind":"company"}},{"role":"legal representative of","share":null,"party":{"id":"76c2477d-e412-5853-a58f-174fb6eb0b08","name":"MICHAEL E. CHAPMAN","type":"Organization","kind":"company"}},{"role":"director of","share":null,"party":{"id":"ee97f76b-3ced-55f9-b30d-02faf3ad3c41","name":"JOHN MILLER","type":"Organization","kind":"company"}},{"role":"legal representative of","share":null,"party":{"id":"ee97f76b-3ced-55f9-b30d-02faf3ad3c41","name":"JOHN MILLER","type":"Organization","kind":"company"}},{"role":"shareholder of","share":null,"party":{"id":"94622a0d-9952-5ea2-b360-4be264e16fab","name":"SHIRE PHARMACEUTICAL HOLDINGS IRELAND LIMITED","type":"Organization","kind":"company"}},{"role":"shareholder of","share":null,"party":{"id":"8b4acc21-eafa-5d1f-81e7-2c8d68a4e1e5","name":"SHIRE EUROPE FINANCE LTD","type":"Organization","kind":"company"}},{"role":"liquidator of","share":null,"party":{"id":"4dd58c0b-bbe6-5980-b3bb-7eab0a22597d","name":"EDWARD GATT","type":"Organization","kind":"company"}}],"holdings":[],"ubo_chain":[{"depth":1,"from":"ed0b7986-578b-5d86-92d0-d3a3b601e2d7","fromName":"MICHAEL C. SCHMIDT","to":"16861bf3-5842-5d52-af27-ab2a3e8d49d7","toName":"SHIRE PHARMACEUTICAL INVESTMENT HOLDINGS LIMITED","role":"secretary of","share":null},{"depth":1,"from":"76c2477d-e412-5853-a58f-174fb6eb0b08","fromName":"MICHAEL E. CHAPMAN","to":"16861bf3-5842-5d52-af27-ab2a3e8d49d7","toName":"SHIRE PHARMACEUTICAL INVESTMENT HOLDINGS LIMITED","role":"director of","share":null},{"depth":1,"from":"76c2477d-e412-5853-a58f-174fb6eb0b08","fromName":"MICHAEL E. CHAPMAN","to":"16861bf3-5842-5d52-af27-ab2a3e8d49d7","toName":"SHIRE PHARMACEUTICAL INVESTMENT HOLDINGS LIMITED","role":"legal representative of","share":null},{"depth":1,"from":"ee97f76b-3ced-55f9-b30d-02faf3ad3c41","fromName":"JOHN MILLER","to":"16861bf3-5842-5d52-af27-ab2a3e8d49d7","toName":"SHIRE PHARMACEUTICAL INVESTMENT HOLDINGS LIMITED","role":"director of","share":null},{"depth":1,"from":"ee97f76b-3ced-55f9-b30d-02faf3ad3c41","fromName":"JOHN MILLER","to":"16861bf3-5842-5d52-af27-ab2a3e8d49d7","toName":"SHIRE PHARMACEUTICAL INVESTMENT HOLDINGS LIMITED","role":"legal representative of","share":null},{"depth":1,"from":"94622a0d-9952-5ea2-b360-4be264e16fab","fromName":"SHIRE PHARMACEUTICAL HOLDINGS IRELAND LIMITED","to":"16861bf3-5842-5d52-af27-ab2a3e8d49d7","toName":"SHIRE PHARMACEUTICAL INVESTMENT HOLDINGS LIMITED","role":"shareholder of","share":null},{"depth":1,"from":"8b4acc21-eafa-5d1f-81e7-2c8d68a4e1e5","fromName":"SHIRE EUROPE FINANCE LTD","to":"16861bf3-5842-5d52-af27-ab2a3e8d49d7","toName":"SHIRE PHARMACEUTICAL INVESTMENT HOLDINGS LIMITED","role":"shareholder of","share":null},{"depth":1,"from":"4dd58c0b-bbe6-5980-b3bb-7eab0a22597d","fromName":"EDWARD GATT","to":"16861bf3-5842-5d52-af27-ab2a3e8d49d7","toName":"SHIRE PHARMACEUTICAL INVESTMENT HOLDINGS LIMITED","role":"liquidator of","share":null}]},"risk":{"level":"HIGH","flags":[],"note":"Risk is a layer-1 signal (offshore-layering / connectivity heuristics) — an investigative lead, not a determination."},"sources":[{"registry":"icij_offshoreleaks","source_url":"https://offshoreleaks.icij.org/nodes/55033389"}],"source":"corpus"}